Nathaniel E. David serves as Executive at KYTHERA BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Nathaniel E. David has executed 59 insider transactions totaling $12.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 1, 2013 involved selling 3,301 shares valued at $88.3K.
Nathaniel E. David currently holds 624,703 shares of KYTHERA BIOPHARMACEUTICALS INC (KYTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nathaniel E. David has been a net seller of KYTH stock. They have purchased $28.5K and sold $12.5M worth of shares.
Nathaniel E. David's most recent insider trade was on Aug 1, 2013, when they sold 3,301 shares at $26.76 per share.
Get notified when new Form 4 filings are submitted
| $27.07 |
| Discretionary |
| Jun 17, 2013 | KYTH | $40.0K | Sale | 1,538 | $26.00 | Discretionary |
| Jun 3, 2013 | KYTH | $41.8K | Sale | 1,969 | $21.23 | Discretionary |
| May 1, 2013 | KYTH | $55.1K | Sale | 2,362 | $23.33 | Discretionary |
| May 1, 2013 | KYTH | $4.8K | Sale | 200 | $24.03 | Discretionary |
| May 1, 2013 | KYTH | $14.4K | Sale | 656 | $22.00 | Discretionary |
| Apr 26, 2013 | KYTH | $56.2K | Sale | 2,500 | $22.48 | Discretionary |
| Oct 16, 2012 | KYTH | $0 | Conversion | 284,574 | $N/A | Discretionary |